Prometheus Therapeutics Inc.
PrivateLast Round
Seed Round
Oct 28, 2025
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Prometheus Therapeutics Inc. is a biotechnology company that develops minimally invasive light-based therapies to stimulate natural cellular regeneration and accelerate healing for vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prometheus Therapeutics Inc. Comparables
Compare Prometheus Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spyre Therapeutics Inc. | 87% | |
| Santa Ana Bio | 84% | |
| NImmune Biopharma | 84% |
Prometheus Therapeutics Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 28, 2025
Raised $2.75M in Seed funding.
Prometheus Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Prometheus Therapeutics Inc.'s valuation, stock price, and market status.
Is Prometheus Therapeutics Inc. a public or private company?
Prometheus Therapeutics Inc. is a private company.
What is the current stock price of Prometheus Therapeutics Inc.?
Prometheus Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Prometheus Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prometheus Therapeutics Inc. worth (valuation)?
Valuation information for Prometheus Therapeutics Inc. is not publicly available.
Can I buy Prometheus Therapeutics Inc. stock?
Prometheus Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prometheus Therapeutics Inc.'s last funding round?
Prometheus Therapeutics Inc.'s most recent funding round was Seed Round on October 28, 2025.
Who are the main investors in Prometheus Therapeutics Inc.?
Investor information for Prometheus Therapeutics Inc. is not publicly disclosed.
Will Prometheus Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Prometheus Therapeutics Inc..
How can I track Prometheus Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Prometheus Therapeutics Inc.'s shares on secondary markets.